The Use of Teacher Metadiscourse in EFL Classrooms: Evidence from One Middle-School and One High-School Lesson
International Journal of New Developments in Education · 2026 · 8 (5)
DOI: 10.25236/ijnde.2026.080501 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of New Developments in Education, 2026.
Abstract (Originalsprache)
: This study compares teacher talk in one middle-school and one high-school EFL lesson to examine cross-level differences in the distribution and density of teachers’ metadiscourse and their functional roles in classroom interaction. Based on lesson transcripts, metadiscourse was categorized and quantified using Hyland’s [1] framework. Frequencies were standardized per 1,000 teacher words. Findings show that although the high-school lesson had a higher raw frequency of metadiscourse, the middle-school lesson displayed greater metadiscourse density and higher interaction-turn density once teacher talk length was controlled. The middle-school classroom showed denser use of frame markers and engagement markers, while the high-school classroom showed denser self-mentions, attitude markers, and boosters. These results suggest that the essential cross-level difference lies in the functional configuration of metadiscourse within classroom progression mechanisms.
Zitieren
APA
(2026). The Use of Teacher Metadiscourse in EFL Classrooms: Evidence from One Middle-School and One High-School Lesson. International Journal of New Developments in Education, 8(5). https://doi.org/10.25236/ijnde.2026.080501
Vancouver
The Use of Teacher Metadiscourse in EFL Classrooms: Evidence from One Middle-School and One High-School Lesson. International Journal of New Developments in Education. 2026;8(5). doi:10.25236/ijnde.2026.080501
BibTeX
@article{euvimed2026,
title = {The Use of Teacher Metadiscourse in EFL Classrooms: Evidence from One Middle-School and One High-School Lesson},
journal = {International Journal of New Developments in Education},
year = {2026},
volume = {8},
number = {5},
doi = {10.25236/ijnde.2026.080501}
}
EUVIMED